{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T03:41:30Z","timestamp":1791776490594,"version":"4.3.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:00:00Z","timestamp":1714694400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009398","name":"RWTH Aachen University Medical Faculty","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009398","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.nano.2024.102751","type":"journal-article","created":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T15:50:49Z","timestamp":1714751449000},"page":"102751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Riboflavin-targeted polymers improve tolerance of paclitaxel while maintaining therapeutic efficacy"],"prefix":"10.1016","volume":"58","author":[{"given":"Milita","family":"Darguzyte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Rama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Rix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin","family":"Baier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sima","family":"Rezvantalab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Khedri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Jankowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Kiessling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"31","key":"10.1016\/j.nano.2024.102751_bb0005","doi-asserted-by":"crossref","first-page":"10330","DOI":"10.1039\/C8DT01585F","article-title":"Why develop photoactivated chemotherapy?","volume":"47","author":"Bonnet","year":"2018","journal-title":"Dalton Trans"},{"issue":"3","key":"10.1016\/j.nano.2024.102751_bb0010","doi-asserted-by":"crossref","DOI":"10.1177\/1559325820936161","article-title":"Nanoparticle-based drug delivery system: a patient-friendly chemotherapy for oncology","volume":"18","author":"Yan","year":"2020","journal-title":"Dose-Response"},{"issue":"326","key":"10.1016\/j.nano.2024.102751_bb0015","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jconrel.2020.07.007","article-title":"Delivering the power of nanomedicine to patients today","author":"Germain","year":"2020","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2024.102751_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114614","article-title":"The tumor EPR effect for cancer drug delivery: current status, limitations, and alternatives","volume":"191","author":"Sun","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"issue":"12_Part_1","key":"10.1016\/j.nano.2024.102751_bb0025","article-title":"A new concept for macromolecular therapeutics in Cancer chemotherapy: mechanism of Tumoritropic accumulation of proteins and the antitumor agent Smancs1","volume":"46","author":"Matsumura","year":"1986","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.nano.2024.102751_bb0030","doi-asserted-by":"crossref","first-page":"956","DOI":"10.7150\/thno.38288","article-title":"Imaging-assisted anticancer nanotherapy","volume":"10","author":"Dasgupta","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.nano.2024.102751_bb0035","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.addr.2017.07.007","article-title":"Pharmacological and physical vessel modulation strategies to improve EPR-mediated drug targeting to tumors","volume":"119","author":"Ojha","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"10.1016\/j.nano.2024.102751_bb0040","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.nano.2024.102751_bb0045","series-title":"Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress. in: nano-enabled medical applications","author":"Storm","year":"2020"},{"issue":"9","key":"10.1016\/j.nano.2024.102751_bb0050","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1021\/acs.bioconjchem.9b00456","article-title":"Insights into active targeting of nanoparticles in drug delivery: advances in clinical studies and design considerations for cancer nanomedicine","volume":"30","author":"Pearce","year":"2019","journal-title":"Bioconjug Chem"},{"issue":"5","key":"10.1016\/j.nano.2024.102751_bb0055","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3390\/cancers11050640","article-title":"Active targeting strategies using biological ligands for nanoparticle drug delivery systems","volume":"11","author":"Yoo","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.nano.2024.102751_bb0060","article-title":"Active targeting drug delivery nanocarriers: ligands","volume":"19","author":"Salahpour","year":"2019","journal-title":"Nano-Struct Nano-Obj"},{"issue":"1","key":"10.1016\/j.nano.2024.102751_bb0065","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1021\/acs.chemrev.1c00484","article-title":"Click and bioorthogonal chemistry: the future of active targeting of nanoparticles for nanomedicines?","volume":"122","author":"Taiariol","year":"2022","journal-title":"Chem Rev"},{"key":"10.1016\/j.nano.2024.102751_bb0070","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.biomaterials.2015.11.050","article-title":"Bioengineered riboflavin in nanotechnology","volume":"80","author":"Beztsinna","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2024.102751_bb0075","article-title":"Evaluation of riboflavin transporters as targets for drug delivery and theranostics","volume":"[cited 2023 Sep 5];10","author":"Bartmann","year":"2019","journal-title":"Front Pharmacol"},{"issue":"8","key":"10.1016\/j.nano.2024.102751_bb0080","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1021\/acs.nanolett.7b01171","article-title":"Balancing passive and active targeting to different tumor compartments using riboflavin-functionalized polymeric nanocarriers","volume":"17","author":"Tsvetkova","year":"2017","journal-title":"Nano Lett"},{"issue":"12","key":"10.1016\/j.nano.2024.102751_bb0085","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1021\/acs.bioconjchem.0c00593","article-title":"Influence of riboflavin targeting on tumor accumulation and internalization of Peptostar based drug delivery systems","volume":"31","author":"Darguzyte","year":"2020","journal-title":"Bioconjug Chem"},{"issue":"1","key":"10.1016\/j.nano.2024.102751_bb0090","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11051-008-9435-7","article-title":"A comparison of atomic force microscopy (AFM) and dynamic light scattering (DLS) methods to characterize nanoparticle size distributions","volume":"10","author":"Hoo","year":"2008","journal-title":"J Nanopart Res"},{"issue":"2","key":"10.1016\/j.nano.2024.102751_bb0095","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.apt.2011.03.009","article-title":"Systematic study of bimodal suspensions of latex nanoparticles using dynamic light scattering","volume":"22","author":"Jamting","year":"2011","journal-title":"Adv Powder Technol"},{"key":"10.1016\/j.nano.2024.102751_bb0100","author":"FDA Approved PEGylated Drugs By 2023 [Internet]"},{"issue":"10","key":"10.1016\/j.nano.2024.102751_bb0105","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.2741\/3477","article-title":"Biochemical characterization of riboflavin carrier protein (RCP) in prostate cancer","volume":"14","author":"Johnson","year":"2009","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10.1016\/j.nano.2024.102751_bb0110","doi-asserted-by":"crossref","DOI":"10.1177\/1534735420924711","article-title":"Evaluation of the efficacy and safety of the herbal formula PM014 in a cisplatin- and paclitaxel-treated tumor-bearing mouse model","volume":"19","author":"Lee","year":"2020","journal-title":"Integr Cancer Ther"},{"key":"10.1016\/j.nano.2024.102751_bb0115","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.2147\/IJN.S188049","article-title":"Chronic chemotherapy with paclitaxel nanoparticles induced apoptosis in lung cancer in vitro and in vivo","volume":"14","author":"Zhao","year":"2019","journal-title":"Int J Nanomedicine"},{"issue":"40","key":"10.1016\/j.nano.2024.102751_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202002054","article-title":"Engineering macrophages for cancer immunotherapy and drug delivery","volume":"32","author":"Xia","year":"2020","journal-title":"Adv Mater"},{"key":"10.1016\/j.nano.2024.102751_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2021.102509","article-title":"Recent advances in active targeting of nanomaterials for anticancer drug delivery","volume":"296","author":"Dutta","year":"2021","journal-title":"Adv Colloid Interf Sci"},{"issue":"9","key":"10.1016\/j.nano.2024.102751_bb0130","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1021\/acs.bioconjchem.6b00317","article-title":"Amphiphilic phospholipid-based riboflavin derivatives for tumor targeting nanomedicines","volume":"27","author":"Beztsinna","year":"2016","journal-title":"Bioconjug Chem"},{"issue":"2","key":"10.1016\/j.nano.2024.102751_bb0135","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1021\/nl404391r","article-title":"Passive versus active tumor targeting using RGD- and NGR-modified polymeric nanomedicines","volume":"14","author":"Kunjachan","year":"2014","journal-title":"Nano Lett"},{"key":"10.1016\/j.nano.2024.102751_bb0140","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.2147\/IJN.S165210","article-title":"Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional\/herbal medicines in cancer therapy: a systematic review","volume":"13","author":"Muhamad","year":"2018","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"10.1016\/j.nano.2024.102751_bb0145","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov"},{"issue":"4","key":"10.1016\/j.nano.2024.102751_bb0150","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/jimd.12058","article-title":"Disorders of riboflavin metabolism","volume":"42","author":"Balasubramaniam","year":"2019","journal-title":"J Inherit Metab Dis"},{"issue":"17","key":"10.1016\/j.nano.2024.102751_bb0155","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1016\/j.bmcl.2010.07.005","article-title":"Design of riboflavin-presenting PAMAM dendrimers as a new nanoplatform for cancer-targeted delivery","volume":"20","author":"Thomas","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.nano.2024.102751_bb0160","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jconrel.2020.07.022","article-title":"Acid-sensitive PEGylated paclitaxel prodrug nanoparticles for cancer therapy: effect of PEG length on antitumor efficacy","volume":"326","author":"Mu","year":"2020","journal-title":"J Control Release"},{"issue":"7","key":"10.1016\/j.nano.2024.102751_bb0165","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1007\/s11095-013-1024-5","article-title":"Riboflavin-targeted polymer conjugates for breast tumor delivery","volume":"30","author":"Bareford","year":"2013","journal-title":"Pharm Res"},{"issue":"12","key":"10.1016\/j.nano.2024.102751_bb0170","doi-asserted-by":"crossref","first-page":"903","DOI":"10.2165\/00002018-200124120-00004","article-title":"A comparison of liposomal formulations of doxorubicin with drug administered in free form","volume":"24","author":"Waterhouse","year":"2001","journal-title":"Drug-Safety"},{"key":"10.1016\/j.nano.2024.102751_bb0175","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/2162-3619-1-10","article-title":"Comparison of safety and toxicity of liposomal doxorubicin vs conventional anthracyclines: a meta-analysis","volume":"1","author":"Rafiyath","year":"2012","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"10.1016\/j.nano.2024.102751_bb0180","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejpb.2004.02.012","article-title":"Synthesis, physico-chemical and biological characterization of a paclitaxel macromolecular prodrug","volume":"58","author":"Cavallaro","year":"2004","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"10.1016\/j.nano.2024.102751_bb0185","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1021\/jm00124a011","article-title":"Synthesis of congeners and prodrugs. 3. Water-soluble prodrugs of taxol with potent antitumor activity","volume":"32","author":"Deutsch","year":"1989","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.nano.2024.102751_bb0190","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1021\/ac034876a","article-title":"Biosensor-based determination of riboflavin in Milk samples","volume":"76","author":"Caelen","year":"2004","journal-title":"Anal Chem"},{"issue":"7","key":"10.1016\/j.nano.2024.102751_bb0195","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1007\/s11095-013-1024-5","article-title":"Riboflavin-targeted polymer conjugates for breast tumor delivery","volume":"30","author":"Bareford","year":"2013","journal-title":"Pharm Res"},{"issue":"17","key":"10.1016\/j.nano.2024.102751_bb0200","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1016\/j.bmcl.2010.07.005","article-title":"Design of riboflavin-presenting PAMAM dendrimers as a new nanoplatform for cancer-targeted delivery","volume":"20","author":"Thomas","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"issue":"39","key":"10.1016\/j.nano.2024.102751_bb0205","doi-asserted-by":"crossref","first-page":"15549","DOI":"10.1073\/pnas.0707461104","article-title":"Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging","volume":"104","author":"Bartlett","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.nano.2024.102751_bb0210","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s11095-016-1908-2","article-title":"Synthesis and in vitro evaluation of polyethylene glycol-paclitaxel conjugates for lung cancer therapy","volume":"33","author":"Luo","year":"2016","journal-title":"Pharm Res"},{"issue":"12","key":"10.1016\/j.nano.2024.102751_bb0215","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/nbm.3431","article-title":"Assessing inflammatory liver injury in an acute CCl4 model using dynamic 3D metabolic imaging of hyperpolarized [1-13C]pyruvate","volume":"28","author":"Josan","year":"2015","journal-title":"NMR Biomed"},{"issue":"1","key":"10.1016\/j.nano.2024.102751_bb0220","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41575-020-0342-4","article-title":"Liver regeneration: biological and pathological mechanisms and implications","volume":"18","author":"Michalopoulos","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963424000200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963424000200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T19:03:18Z","timestamp":1716663798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963424000200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":44,"alternative-id":["S1549963424000200"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2024.102751","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Riboflavin-targeted polymers improve tolerance of paclitaxel while maintaining therapeutic efficacy","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2024.102751","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102751"}}